Dmitry Balyasny’s PharMerica Corporation PMC Stock Holding History

Dmitry Balyasny’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,797	Closed	-$228K	–	2514
2017 Q3	$228K	Buy	+7,797	New	+$218K	﹤0.01%	1652
2017 Q1	–	Sell	-61,990	Closed	-$1.56M	–	1887
2016 Q4	$1.56M	Sell	61,990 -642,967	-91%	-$16.2M	0.01%	927
2016 Q3	$19.8M	Buy	+704,957	New	+$18.1M	0.11%	247
2016 Q2	–	Sell	-91,240	Closed	-$2.02M	–	1599
2016 Q1	$2.02M	Buy	+91,240	New	+$2.43M	0.01%	693
2015 Q2	–	Sell	-12,840	Closed	-$362K	–	1439
2015 Q1	$362K	Buy	+12,840	New	+$319K	﹤0.01%	751

Dmitry Balyasny's PMC Position: Q4 2017 in Review

Dmitry Balyasny sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 7,797 shares — an estimated $228K sold.

Dmitry Balyasny first reported a position in PMC in Q1 2015 and held it in 5 quarters. The position peaked at $19.8M in Q3 2016. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

Dmitry Balyasny reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
Dmitry Balyasny sold 7,797 PharMerica Corporation shares in Q4 2017, an estimated $228K.
Dmitry Balyasny first reported a position in PharMerica Corporation in Q1 2015 and held it in 5 quarters.
Dmitry Balyasny's PharMerica Corporation position peaked at $19.8M in Q3 2016.
0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.